Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $2.49B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 ·
Decision snapshot: FIVN stock price vs VRTX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at VRTX's multiple
Needs VRTX P/E.
Implied fair value · at FIVN's multiple
Needs FIVN P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: FIVN FY 2025 (ended Dec 31, 2025) · VRTX FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 75% equity / 25% debt · EV / Revenue 2.66x · EV / EBITDA 22.40x
Capital structure 97% equity / 3% debt · EV / Revenue 11.34x · EV / EBITDA 27.98x
VRTX carries the larger enterprise value at $136.05B against $3.06B; FIVN trades on the lower EV / Revenue multiple (2.66x vs 11.34x); FIVN on the lower EV / EBITDA (22.40x vs 27.98x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Five9, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
VERTEX PHARMACEUTICALS INC / MA · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.03x
0.23x
Net debt / EBITDA
Leverage against operating earnings
4.21x
-0.49x
Cash and equivalents
Liquid reserves on the balance sheet
$232.08M
$6.61B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
RingCentral, Inc.
FIVN vs RNG
8X8 INC /DE/
FIVN vs EGHT
Zoom Communications, Inc.
FIVN vs ZM
PEGASYSTEMS INC
FIVN vs PEGA
VERINT SYSTEMS INC
FIVN vs VRNT
AMGEN INC
FIVN vs AMGN
Gilead Sciences, Inc.
FIVN vs GILD
BIOGEN INC.
FIVN vs BIIB
Moderna, Inc.
FIVN vs MRNA
Illumina, Inc.
FIVN vs ILMN
$807.25M
$4.23B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
